NASD · Healthcare · Biotechnology · Australia
Kazia Therapeutics Limited ADR is a micro cap company (market value under $300 million) in the Biotechnology industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Kazia Therapeutics Limited ADR stock.
Not valued: We cannot value this company yet.
We do not publish a value for this company: its filings do not cover four fiscal years in a row, which projecting growth needs.
134 more in this industry show a wider margin of safety.
We do not publish a verdict on KZIA yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive do not cover four fiscal years in a row. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.
We do not publish one (as of the 2026-10-30 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive do not cover four fiscal years in a row. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.